Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
What dose constraints, if any, do you use for the thyroid gland when treating with regional nodal irradiation for breast cancer?
Answer from: Radiation Oncologist at Community Practice
I have not used any constraints for thyroid for RNI but based on the volume, dose is confined to ipsilateral lobe of thyroid.
Sign in or Register to read more
5899
Related Questions
When should the dissected axilla (levels I-II) be included when delivering RNI?
Does radiation therapy (ex. to the breast) in patients with CDK4 mutations increase the risk of developing melanoma?
In patients with HER-2 positive breast cancer on pertuzumab/trastuzumab with newly developed asymptomatic brain metastases only, do you wait 3 weeks after administration of the targeted therapy to deliver SRS?
Do you consider chest wall constraints when treating with 5-fraction APBI?
What is the earliest you would start postmastectomy radiation after adjuvant chemotherapy for a patient with breast cancer?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
In patients with history of prior axillary surgery, subsequently with breast cancer recurrence, and sentinel lymph nodes mapped to internal mammary area (but were not biopsied), do you offer post-mastectomy radiation to cover the IMNs?
What hotspot and heterogeneity metrics do you utilize when delivering PMRT to a patient who has had breast reconstruction?
Would you offer ultra-hypofractionated accelerated partial breast re-irradiation using 5 fractions?
Is it appropriate to use bolus with hypofractionated PMRT?